Biolase, inc (BIOL)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09
Cash Flows from Operating Activities:
Net loss

-17,855

-21,516

-16,851

-15,371

-

-

-

-

-

-

-

Net loss

-

-

-

-

-20,278

-18,926

-11,482

-3,056

-4,486

-12,021

-2,956

Adjustments to reconcile net loss to net cash and cash equivalents used in operating activities:
Depreciation and amortization

982

945

1,203

1,048

880

696

601

513

695

1,070

1,444

Loss on disposal of assets, net

-

-1,228

-505

2

-6

-9

-

-15

-

-

-

Loss (gain) on disposal of property, plant, and equipment, net

-

-

-

-

-

-

-

-

-36

-55

-13

Impairment of property, plant and equipment

-

-

-

-

-

-

-

-

-

35

-

Provision for bad debts

1,695

469

40

-118

86

1,295

291

241

74

-80

-

Provision for inventory excess and obsolescence

413

166

623

272

647

585

1,132

330

392

-

-

Provision for sales returns allowance

-

-

-

-

100

-

-

-

-

-

-

Amortization of discounts on lines of credit

140

202

-

-

-

200

179

43

-

-

-

Provision for bad debts

-

-

-

-

-

-

-

-

-

-

62

Recovery of sales returns allowance

-

-

-

-

-

-

-

-

-

-

-77

Provision for inventory excess and obsolescence

-

-

-

-

-

-

-

-

-

-

-1,090

Amortization of discounts on term loan payable

-

-

-

-

-

-

-

-

78

37

-

Amortization of debt issuance costs

188

126

-

-

-

128

197

91

99

70

-

Stock-based compensation

2,742

2,768

2,207

3,065

3,350

1,233

-

1,600

1,528

727

1,357

Warrants issued to consultants

-48

-

-

-

-

-

-

-

-

-

-

Other equity instruments compensation

-

-

-

-

-

-

106

23

-

-

-

Other equity instruments compensation

-

-

-

-

-

-

-

-

273

19

-

Other non-cash compensation

-

-

-

-

-

-123

-250

-250

-250

-87

-

Stock-based compensation

-

-

-

-

-

-

1,609

-

-

-

-

Deferred income taxes

7

-27

-694

60

61

60

-30

61

53

76

109

Earned interest income, net

-2

-1

42

-

-

-

-

-

-

-

-

Earned interest income

-

-

-

70

74

-

-27

-

-

-

-

Change in fair value of patent litigation settlement liability

-

-1,500

-

-

-

-

-

-

-

-

-

Incurred but unpaid interest expense

-

-

-

-

-

-

-

19

-

-

-

Changes in operating assets and liabilities:
Restricted cash

-

-

-

-

200

-

-

-

-

-

-

Accounts receivable

-655

1,458

337

644

52

-826

-264

3,222

5,642

-978

290

Inventory

-840

127

-419

1,989

705

1,715

1,436

160

4,716

-874

-3,459

Prepaid expenses and other current assets

-439

25

11

-79

65

21

-56

-450

552

-173

275

Customer deposits

-

-

-

-

-27

-174

-297

417

-5,711

5,877

-

Accounts payable and accrued liabilities

-3,156

1,762

-5,077

3,338

-640

451

-999

-347

4,230

-773

-4,990

Deferred revenue

114

-161

-397

-264

-

-

-

-

-

-

-

Accrued legal settlement

-

-

-

-

1,664

-

-

-

-

-

-

Deferred revenue

-

-

-

-

803

-971

236

1,068

79

-1,016

-1,393

Net cash and cash equivalents used in operating activities

-

-

-

-

-17,772

-16,201

-9,296

-1,664

-

-

-

Net cash and cash equivalents used in operating activities

-12,746

-14,147

-18,412

-10,596

-

-

-

-

-13,320

-3,812

-2,571

Cash Flows from Investing Activities:
Purchases of property, plant, and equipment

207

558

747

1,414

1,803

198

675

808

428

237

449

Proceeds from disposal of property, plant, and equipment

-

36

-

-

25

1

-

-

-

-

5

Net cash and cash equivalents used in investing activities

-207

-522

-747

-1,414

-

-

-

-

-428

-237

-444

Cash Flows from Financing Activities:
Proceeds from disposal of long-lived assets

-

-

-

-

-

-

-

124

-

-

-

Purchased other intangible assets

-

-

-

-

-

-

10

14

-

-

-

Net cash and cash equivalents used in investing activities

-

-

-

-

-1,778

-197

-685

-698

-

-

-

Principal payments under capital lease obligation

-

46

146

171

107

-

-

-

-

-

-

Borrowings under lines of credit

-

3,696

-

-

-

16,875

35,100

16,600

-

-

-

Payments under lines of credit

-

3,696

-

-

-

21,508

32,104

14,963

-

-

-

Borrowings under line of credit

-

-

-

-

-

-

-

-

-

-

4,293

Payments under line of credit

-

-

-

-

-

-

-

-

-

-

9,697

Proceeds from term loan

2,500

12,500

-

-

-

-

-

-

-

3,000

-

Payments under term loan payable

-

-

-

-

-

-

-

-

2,700

300

-

Payments of debt issuance costs

133

1,058

-

-

-

45

57

304

-

85

-

Proceeds from exercise of warrants

-

-

-

-

-

-

-

6

18

-

-

Payment to repurchase equity warrants

-

-

-

-

-

-

-

-

130

-

-

Proceeds from equity offerings

9,171

-

21,761

9,520

-

51,118

5,201

-

17,223

-

-

Payments of fees for shelf registration

821

164

-

-

-

-

-

-

-

-

-

Proceeds from exercise of stock options

4

3

3

1

-

-

-

-

-

-

-

Deposit on capital lease

-

-

-

-

42

-

-

-

-

-

-

Proceeds from exercise of stock options

-

-

-

-

44

312

707

-

1,244

199

173

Stock repurchase

-

-

-

-

-

-

-

235

268

-

-

Proceeds from exercise of stock options

-

-

-

-

-

-

-

455

-

-

-

Net cash and cash equivalents provided by (used in) financing activities

-

-

-

-

-105

46,752

8,847

1,559

-

-

-

Net cash and cash equivalents (used in) provided by financing activities

10,721

11,235

21,618

9,350

-

-

-

-

15,387

2,814

-5,231

Effect of exchange rate changes

-23

-106

262

-64

-206

-234

31

39

-26

-46

-14

Decrease in cash, cash equivalents and restricted cash

-2,255

-3,540

2,721

-2,724

-

-

-

-

-

-

-

Increase (decrease) in cash and cash equivalents

-

-

-

-

-19,861

30,120

-1,103

-764

1,613

-1,281

-8,260

Supplemental cash flow disclosure:
Cash paid for interest

1,784

23

1

4

-

-

-

-

-

-

-

Interest received

-

-

74

74

-

-

-

-

-

-

-

Interest paid

-

-

-

-

4

148

220

88

80

236

58

Cash paid for income taxes

35

44

164

76

57

52

47

62

44

-96

34

Cash paid for operating leases

797

-

-

-

-

-

-

-

-

-

-

Supplemental cash flow disclosure - Non-cash investing and financing activities
Assets acquired under capital lease

-

-

-

-

378

-

-

-

-

-

-

Non-cash accrual for capital expenditures

18

31

102

251

1,137

-

-

-

-

-

-

Loss on patent litigation settlement

-

1,500

-

-

-

-

-

-

-

-

-

Settlement of liability awards with RSUs

201

-

-

-

-

-

-

-

-

-

-

Right of Use Assets obtained in exchange for a lease liability

276

-

-

-

-

-

-

-

-

-

-

Equity financing costs in accounts payable

129

-

-

-

-

-

-

-

-

-

-

Warrants issued in connection with debt instruments

161

847

-

-

-

-

-

-

-

-

-

Intangible assets acquired for accounts receivable reduction

-

-

-

-

-

-

-

200

-

-

-